RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.

TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Skye Bioscience (SKYE – Research Report), Eton ...

Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.29 per share a year ago. These figures are ...

Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 16,769.77 Crore) operating in Pharmaceuticals sector. Eris Lifesciences Ltd. key Products/Revenue ...

Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...